Latest news and press releases about Quantum BioPharma Ltd. (QNTM): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
Price
| Price | $3.65 |
| Market Cap | $23M |
| Exchange | NASDAQ |
| Country | CA |
Related companies: ANVS · ATNM · BCAB · CELU · CPIX · EVAX · PYPD
Explore sector: Healthcare · Biotechnology
More sections of QNTM: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks